...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma.
【24h】

The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma.

机译:E3泛素连接酶UBR5在套细胞淋巴瘤中反复突变。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We have recently reported the application of RNAseq to mantle cell lymphoma (MCL) transcriptomes revealing recurrent mutations in NOTCH1. Here we describe the targeted resequencing of 18 genes mutated in this discovery cohort using a larger cohort of MCL tumors. In addition to frequent mutations in ATM, CCND1, TP53, and NOTCH1, mutations were also observed recurrently in MEF2B, TRAF2, and TET2. Interestingly, the third most frequently mutated gene was UBR5, a gene encoding a 2799aa protein, with multiple functions, including E3 ligase activity based on a conserved cysteine residue at the C-terminus. Nonsynonymous mutations were detected in 18% (18/102) of tumors, with 61% of the mutations resulting in frameshifts in, or around, exon 58, predicted to result in the loss of this conserved cysteine residue. The recurrence and clustering of deleterious mutations implicate UBR5 mutations as a critical pathogenic event in a subgroup of MCL.
机译:我们最近报道了RNAseq在揭示NOTCH1反复突变的套细胞淋巴瘤(MCL)转录组中的应用。在这里,我们描述了使用较大的MCL肿瘤队列在此发现队列中突变的18个基因的靶向重测序。除了ATM,CCND1,TP53和NOTCH1中的频繁突变外,在MEF2B,TRAF2和TET2中也经常观察到突变。有趣的是,第三最频繁突变的基因是UBR5,该基因编码2799aa蛋白,具有多种功能,包括基于C端半胱氨酸保守的E3连接酶活性。在18%(18/102)的肿瘤中检测到非同义突变,其中61%的突变导致外显子58或其周围发生移码,预计会导致该保守的半胱氨酸残基丢失。有害突变的复发和聚类表明UBR5突变是MCL亚组中的关键致病事件。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号